GSK-1004723

DB12806InvestigationalSmall molecule

Gsk1004723 has been investigated for the treatment of Allergic Rhinitis and Rhinitis, Allergic, Seasonal.

Chemical structure of GSK-1004723
Mechanism
Curator reviewed
Formula / weight
C39H49ClN4O2 · 641.3 g/mol (avg)
Code names
GSK1004723

Resolves to

Compound
UNIIS08212J4ZRCAS955359-72-5ChEMBLCHEMBL1767164PubChem17747460
Structure
InChIKeyYANGEESWIGIKOP-UUWRZZSWSA-NSMILESClC1=CC=C(CC2=NN(C[C@H]3CCCN3CCCCC3=CC=C(OCCCN4CCCCCC4)C=C3)C(=O)C3=CC=CC=C23)C=C1
Targets
P35367HRH1Q9Y5N1HRH3

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
31Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with GSK-1004723, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In